Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19240051 | 0.85 | MAPT (0.45) | MEN1ALDH1A1MAPTRECQLKMT2A | |
| SCHEMBL19240052 | 0.83 | MAPT (0.43) | MEN1ALDH1A1MAPTRECQLKMT2A | |
| SCHEMBL19240033 | 0.78 | ALDH1A1 (0.40) | MEN1ALDH1A1MAPTKMT2AKDM4C | |
| SCHEMBL19240074 | 0.73 | ALDH1A1 (0.46) | MEN1ALDH1A1MAPTKMT2ATP53 | |
| SCHEMBL9889302 | 0.73 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL19240068 | 0.73 | KMT2A (0.39) | MEN1ALDH1A1MAPTRECQLKMT2A | |
| SCHEMBL19240086 | 0.72 | MAPT (0.55) | MEN1ALDH1A1MAPTKMT2A | |
| SCHEMBL19240076 | 0.70 | ALDH1A1 (0.47) | MEN1ALDH1A1MAPTKMT2ATP53 | |
| SCHEMBL19240044 | 0.70 | MEN1 (0.40) | MEN1ALDH1A1MAPTRECQLKMT2A | |
| SCHEMBL19240087 | 0.69 | MAPT (0.56) | MEN1ALDH1A1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8652364-B2 | Polymer film, ultraviolet absorber, merocyanine compound and process for preparing merocyanine compound | FUJIFILM CORPORATION (JP) | 2014-02-18 | — | — | US | disclosed |
| US-8652364-B2 | Polymer film, ultraviolet absorber, merocyanine compound and process for preparing merocyanine compound | FUJIFILM CORPORATION (JP) | 2014-02-18 | — | — | US | disclosed |
| US-20120140161-A1 | POLYMER FILM, RETARDATION FILM, POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND ULTRAVIOLET ABSORBER | FUJIFILM CORPORATION (JP) | 2012-06-07 | — | — | US | disclosed |
| US-20110229662-A1 | Polymer film, production method for the film, and retardation film, polarizing plate and liquid-crystal display device having the film | FUJIFILM CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
| US-20110229662-A1 | Polymer film, production method for the film, and retardation film, polarizing plate and liquid-crystal display device having the film | FUJIFILM CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
| US-20110220843-A1 | POLYMER FILM, ULTRAVIOLET ABSORBER, MEROCYANINE COMPOUND AND PROCESS FOR PREPARING MEROCYANINE COMPOUND | FUJIFILM CORPORATION (JP) | 2011-09-15 | — | — | US | disclosed |
| US-20110220843-A1 | POLYMER FILM, ULTRAVIOLET ABSORBER, MEROCYANINE COMPOUND AND PROCESS FOR PREPARING MEROCYANINE COMPOUND | FUJIFILM CORPORATION (JP) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110220843-A1 | POLYMER FILM, ULTRAVIOLET ABSORBER, MEROCYANINE COMPOUND AND PROCESS FOR PREPARING MEROCYANINE COMPOUND | HAMP, CRY1, CRY2 | MEN1 48/4885ALDH1A1 1899/4885MAPT 1831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.